Introduction {#sec1-1}
============

Currarino syndrome (CS) is a hereditary disorder characterized by the classical triad of sacral agenesis, anorectal malformation, and a presacral mass. It was first described by Currarino *et al.* and considered the result of abnormal endoectodermal adhesions and notochordal defects in early fetal life.\[[@ref1]\] The phenotypic expression of CS is variable.\[[@ref2][@ref3][@ref4]\] Some patients are asymptomatic and incidentally diagnosed late in life, whereas the illness is fatal in infancy in other cases because of severe complications such as bacterial meningitis and urinary tract infections. Malignancy in CS is rare, with a reported frequency of approximately 1%.\[[@ref2][@ref5]\] Concerning malignancy in adults with CS, only six cases have been described to date \[[Table 1](#T1){ref-type="table"}\].\[[@ref6][@ref7][@ref8][@ref9][@ref10][@ref11]\] This case report is the first documented instance of presacral teratoma associated with CS coexisting with both adenocarcinoma and a neuroendocrine tumor.

###### 

Malignancy in adults with Currarino syndrome

  Author, year                Age, sex     CS diagnosis     Malignant tumor                                                   Treatment
  --------------------------- ------------ ---------------- ----------------------------------------------------------------- -----------------------
  Ashcraft *et al*., 1974     32, female   Clinical         Malignant presacral teratoma                                      Not described
  Yates *et al*., 1983        54, male     Clinical         Malignant presacral teratoma                                      Surgery
  Norum *et al*., 1991        59, female   Clinical         Presacral leiomyosarcoma                                          Surgery, radiotherapy
  Urioste *et al*., 2004      22, male     HLXB9 mutation   Neuroendocrine tumor from presacral teratoma                      Surgery, chemotherapy
  Pendlimari *et al*., 2010   22, female   Clinical         Neuroendocrine tumor from presacral teratoma                      Surgery
  Ciotti *et al*., 2011       44, female   HLXB9 mutation   Neuroendocrine tumor from presacral teratoma                      Surgery, chemotherapy
  Present case                59, female   Clinical         Adenocarcinoma and neuroendocrine tumor from presacral teratoma   Surgery, radiotherapy

Case Report {#sec1-2}
===========

A 59-year-old Japanese woman with hypertension and diabetes mellitus was admitted to our hospital to undergo pelvic surgery. She had a presacral mass that was incidentally detected on CT before cholecystectomy for cholelithiasis, and adenocarcinoma was detected in the mass via endoscopic ultrasound-guided fine needle aspiration through the rectum in a prior hospital. Complete blood count, liver function, basic metabolic panel, and urinalysis were unremarkable. CEA, CA19-9, and CA125 were within their normal ranges.

A pelvic radiograph revealed a scimitar sacrum with a right-sided defect \[[Figure 1](#F1){ref-type="fig"}\]. Contrast-enhanced CT revealed two presacral masses in the pelvis. The upper mass had cystic and solid components containing subtle calcification, and the second mass was a simple cyst through an enlarged neural foramen \[[Figure 2](#F2){ref-type="fig"}\]. Pelvic MRI illustrated the upper mass with cystic and solid components with various intensities on T1- and T2-weighted images (T2WI). The other presacral cystic lesion displayed high intensity on T2WI, and it had no mural nodule, which was suggestive of an anterior meningocele \[[Figure 3](#F3){ref-type="fig"}\]. The patient was diagnosed with a malignant tumor associated with CS preoperatively, and she underwent surgical resection of the presacral mass in the pelvis. The tumor was completely resected, although the lower cystic lesion was accidentally ruptured because of adhesion.

![Pelvic X-ray revealed a scimitar sacrum with a right-sided defect](IJRI-29-327-g001){#F1}

![Contrast-enhanced CT revealed two presacral masses in the pelvis. One mass had cystic and solid components containing subtle calcification (arrowhead). The other mass was a cystic lesion through an enlarged neural foramen (arrow)](IJRI-29-327-g002){#F2}

![Pelvic MRI revealed cystic and solid components with various intensities on T1- and T2-weighted images (arrowheads). The other presacral cystic lesion exhibited high intensity on T2-weighted images, and it featured no mural nodule (arrows)](IJRI-29-327-g003){#F3}

Pathologic examination confirmed that the cystic and solid tumor contained adenocarcinoma and neuroendocrine tumor (NET) components (G2) \[[Figure 4](#F4){ref-type="fig"}\]. The resected tumor included many cysts covered by stratified columnar epithelium, smooth muscle tissues, and a glomus tumor. Subtle fat tissue was present in the resected tumor, although it was not detected on preoperative MRI. Histologically, the tumor contained several different tissue types, suggesting a teratomatous nature. Most cysts inside the tumor that exhibited varied intensity on MRI included necrotic tissues. Adenocarcinoma was found in the cyst-like structure, and it was not distinguishable from other cysts on preoperative image examinations \[[Figure 5](#F5){ref-type="fig"}\]. The adenocarcinoma component exhibited ductal and papillary structures, and a diagnosis of moderately differentiated adenocarcinoma was rendered. In the NET component, which was close to the adenocarcinoma lesion, immunohistochemical staining was positive for synaptophysin and chromogranin A. Residual NET tissue was observed along the surgical margins, and postoperative adjuvant radiotherapy (50.4 Gy/28 fr) was administered without adjuvant chemotherapy. After 8 months of follow-up, contrast-enhanced CT and pelvic MRI revealed no tumor recurrence, but genetic testing has not been performed in line with the patient\'s preference.

![(A) Moderately differentiated adenocarcinoma, H and E stain. (B) Neuroendocrine tumor, synaptophysin stain. The histological presence of a neuroendocrine tumor, smooth muscle tissue, cysts covered by stratified squamous epithelium, and glomus tumor suggested a teratomatous nature (not shown)](IJRI-29-327-g004){#F4}

![(A and B) The presacral tumor near the rectum contained cysts with varied intensity on MRI. One of these cysts included adenocarcinoma](IJRI-29-327-g005){#F5}

Discussion {#sec1-3}
==========

CS is a rare autosomal dominant disorder, and mutations in the coding sequence of HLXB9 located at 7q36 have been identified in nearly all cases of familial CS, as well as approximately 30% of patients with sporadic CS.\[[@ref2]\] Sacral defects in CS vary from lateral deviation of the coccygeal bone to a hemisacrum or the absence of the lower sacral segments.\[[@ref2][@ref3][@ref4]\] Presacral masses contain anterior myelomeningocele, malignant or benign teratoma, dermoid or epidermoid cysts, leiomyoma, leiomyosarcoma, lipoma, or combinations of these lesions. More than 80% of patients with the classic triad are diagnosed within the first decade of life because of the symptoms of anorectal malformation.\[[@ref12]\] However, one-third of patients are asymptomatic at the time of diagnosis.\[[@ref2]\] The combination of all three defects is not necessary for a diagnosis of CS because the clinical presentation of the syndrome is variable. Although genetic tests have not been performed, the present case featured a hemisacrum and a presacral mass with anterior meningocele, and no anorectal malformation was present, suggesting the mild type of CS in the classification by Martucciello *et al.*\[[@ref4]\] Therefore, the present case was diagnosed incidentally at older age than typical cases.

Malignancy in CS is rare. Only a small number of patients of CS with malignancy have been reported. The risk of malignant transformation of presacral teratomas was estimated in previous reports at around 1% of CS cases.\[[@ref2][@ref5]\] On top of that, as for malignancy in adults with CS, only six cases have been described until now \[[Table 1](#T1){ref-type="table"}\].\[[@ref6][@ref7][@ref8][@ref9][@ref10][@ref11]\] The median age of diagnosis for CS with malignancy is 38 years (range, 22--59). Among the previously reported cases, HLXB9 mutations were detected in two cases, and the remaining cases were diagnosed as CS clinically. NETs from presacral teratoma were reported in three cases, and malignant tumors were associated with presacral teratoma in all but one case of leiomyosarcoma. Surgical resection of a presacral mass carries risks of severe complications related to adhesion of the anterior meningocele such as bacterial meningitis and cerebrospinal fluid leakage.\[[@ref13]\] In our case, although the anterior meningocele was accidentally ruptured during surgery, no severe postoperative complication occurred.

In general, somatic malignant transformation of mature cystic teratoma is uncommon, and the risk of transformation is estimated at 1%--3%.\[[@ref14][@ref15]\] Although any tissue component of a teratoma can potentially undergo malignant transformation, squamous cell carcinoma is the most commonly associated malignancy. Other reported malignant tumors arising within a mature cystic teratoma include adenocarcinoma, basal cell carcinoma, adenosquamous carcinoma, thyroid carcinoma, sebaceous carcinoma, malignant melanoma, sarcoma, carcinoid tumor (NET), and neuroectodermal tumor.\[[@ref16][@ref17]\] A synchronous primary neuroendocrine tumor and primary adenocarcinoma arising within mature cystic teratoma is extremely rate, and only five cases have been reported \[[Table 2](#T2){ref-type="table"}\].\[[@ref18][@ref19][@ref20][@ref21][@ref22]\] To the best of our knowledge, no prior report described a mature cystic teratoma in CS coexisting with both adenocarcinoma and NET.

###### 

Clinical characteristics of adenocarcinoma and neuroendocrine tumor arising from mature cystic teratoma

  Author, year             Age, sex     Symptoms                      Lesion site                             Treatment                                           Follow-up
  ------------------------ ------------ ----------------------------- --------------------------------------- --------------------------------------------------- --------------------------------------------------------------
  Kim *et al*., 2003       62, female   Lower abdominal pain          Ovary                                   Hysterectomy with BSO, chemotherapy, radiotherapy   Alive without evidence of disease at 13 months after surgery
  Armah *et al*., 2009     50, female   Low back and right hip pain   Horseshoe kidney                        Partial nephrectomy                                 Alive without evidence of disease at 6 months after surgery
  Hinshaw *et al*., 2012   74, female   Incidental finding on CT      Ovary                                   Hysterectomy with BSO                               Not described
  Agarwal *et al*., 2015   24, female   Chest pain                    Mediastinum                             Surgical resection                                  Alive without evidence of disease at 1 month after surgery
  Higgins *et al*., 2017   66, male     Epigastric pain               Horseshoe kidney                        Partial nephrectomy, chemotherapy                   Died 7 months after surgery from metastatic disease
  Present case             59, female   Incidental finding on CT      Presacral teratoma associated with CS   Surgical resection, radiotherapy                    Alive without evidence of disease at 6 months after surgery

BSO=Bilateral salpingo-oophorectomy; CS=Currarino syndrome

Conclusion {#sec1-4}
==========

CS is a rare congenital disease with variable phenotypic expression, thereby producing a range of symptoms. The occurrence of synchronous primary adenocarcinoma and NET arising within a teratoma is rare. The present patient was diagnosed with CS incidentally in middle age, and this is the first reported case to our knowledge of a mature cystic teratoma coexisting with adenocarcinoma and NET in a patient with CS.
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